Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT05179356
Status:
RECRUITING
Last Update Posted:
2023-12-15
First Post:
2021-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dapagliflozin in Pulmonary Arterial Hypertension
Sponsor:
Mads Ersbøll
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-16
First Submit QC Date:
None
Study First Post Date:
2022-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-14
Last Update Post Date:
2023-12-15
Last Update Post Date Type:
ACTUAL